|
|
细菌溶解产物在治疗儿童呼吸系统疾病中的研究进展
|
Abstract:
儿童的健康成长是每个家庭的重心之一。儿童常见的呼吸系统疾病给大多家庭带来了不少困扰，甚至成为整个社会重要的疾病负担及医疗挑战。随着科研水平及医疗技术的不断发展，免疫调节剂应用而生，细菌溶解产物作为其中的一种，在儿童呼吸系统疾病中的应用亦较为广泛。本文就细菌溶解产物在治疗儿童呼吸系统疾病中的研究进展进行综述，为细菌溶解产物在儿童呼吸系统疾病的应用提供科学依据。
The healthy growth of children is one of the focuses of every family. Common respiratory system diseases in children have caused a lot of trouble to most families, and even become an important disease burden and medical challenge for the whole society. With the continuous development of scientific research and medical technology, the application of immunomodulators is born, and bacterial lysates, as one of them, are also widely used in children’s respiratory system diseases. In this paper, the research progress of bacterial lysate in the treatment of children’s respiratory system diseases was reviewed, providing scientific basis for the application of bacterial lysate in children’s respiratory system diseases.
| [1] | Zagar, S. and L？fler-Badzek, D. (1988) Broncho-Vaxom in Children with Rhinosinusitis: A Double-Blind Clinical Trial. ORL: Journal for Oto-Rhino-Laryngology and Its Related Specialties, 50, 397-404. https://doi.org/10.1159/000276020 |
| [2] | 张志英. 泛福舒联合布地奈德对哮喘患儿呼吸功能及血清IL-4、IL-10水平的影响的研究[J]. 辽宁医学杂志, 2021, 35(1): 3-6. |
| [3] | Mauel, J., Van Pham, T., Kreis, B., et al. (1989) Stimulation by a Bacterial Extract (Broncho-Vaxom) of the Metabolic and Functional Activities of Murine Macrophages. International Journal of Immunopharmacology, 11, 637-645. https://doi.org/10.1016/0192-0561(89)90149-5 |
| [4] | Rossi, G.A., Pohunek, P., Feleszko, W., et al. (2020) Viral Infections and Wheezing-Asthma Inception in Childhood: Is There a Role for Immunomodulation by Oral Bacterial Lysates? Clinical and Translational Allergy, 10, Article No. 17. https://doi.org/10.1186/s13601-020-00322-1 |
| [5] | Yin, J., Xu, B., Zeng, X., et al. (2018) Broncho-Vaxom in Pediatric Recurrent Respiratory Tract Infections: A Systematic Review and Meta-Analysis. International Immunopharmacology, 54, 198-209. https://doi.org/10.1016/j.intimp.2017.10.032 |
| [6] | GBD 2015 Chronic Respiratory Disease Collaborators (2017) Global, Regional, and National Deaths, Prevalence, Disability-Adjusted Life Years, and Years Lived with Disability for Chronic Obstructive Pulmonary Disease and Asthma, 1990-2015: A Systematic Analysis for the Global Burden of Disease Study 2015. The Lancet Respiratory Medicine, 5, 691-706. https://doi.org/10.1016/S2213-2600(17)30293-X |
| [7] | 谢书琳, 薛勇达, 陈晓颖, 林璐璐, 唐周凤, 陈霞. 2326例儿童呼吸道病原体感染情况分析[J]. 中国医药指南, 2024, 22(1): 45-47. |
| [8] | 王长举, 焦瑞南. 布地奈德联合细菌溶解产物胶囊治疗对反复呼吸道感染患儿免疫功能、炎症反应和气道重塑的影响[J]. 内科, 2022, 17(6): 626-629. |
| [9] | Esposito, S., Bianchini, S., Bosis, S., et al. (2019) A Randomized, Placebo-Controlled, Double-Blinded, Single-Centre, Phase IV Trial to Assess the Efficacy and Safety of OM-85 in Children Suffering from Recurrent Respiratory Tract Infections. Journal of Translational Medicine, 17, Article No. 284. https://doi.org/10.1186/s12967-019-2040-y |
| [10] | 戎萍, 马融, 张喜莲, 闫海虹. 细菌溶解产物胶囊防治儿童反复呼吸道感染有效性和安全性的Meta分析[J]. 中国药房, 2018, 29(12): 1702-1706. |
| [11] | 潘笑悦. 泛福舒在呼吸道感染合并肾病综合征儿童复发中防治作用[J]. 包头医学院学报, 2019, 35(2): 20-22. |
| [12] | 中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南(2020年版) [J]. 中华结核和呼吸杂志, 2020, 43(12): 1023-1048. |
| [13] | 杨勇, 宋俊杉, 张环, 朗玥, 徐建波. 泛福舒胶囊联合参麦注射液治疗儿童支气管哮喘的疗效及对血清IL-4、hs-CRP、Ang-2的影响[J]. 现代生物医学进展, 2018, 18(6): 1133-1136 1019. |
| [14] | Qian, J., Xu, Y.Q. and Yu, Z.W. (2018) Budesonide and Calcitriol Synergistically Inhibit Airway Remodeling in Asthmatic Mice. Canadian Respiratory Journal, 2018, Article ID: 5259240. https://doi.org/10.1155/2018/5259240 |
| [15] | 方芬, 周红霞, 张蓓蓓. 细菌溶解产物、孟鲁司特钠联合哌拉西林他唑巴坦对社区获得性肺炎伴哮喘患儿治疗效果的观察[J]. 中国处方药, 2022, 20(10): 125-127. |
| [16] | 毛成立. 泛福舒联合沙丁胺醇雾化吸入治疗小儿支气管哮喘的效果及对免疫功能的影响[J]. 河南医学研究, 2020, 29(20): 3759-3761. |
| [17] | 尹莉莉, 李伟, 殷爱云, 张永燕. 孟鲁司特钠联合细菌溶解产物对哮喘患儿IL-33、sST2受体、EOS、ECP的影响[J]. 中华肺部疾病杂志(电子版), 2021, 14(6): 803-805. |
| [18] | 王娟. 细菌溶解产物胶囊联合吸入用糖皮质激素及β2受体兴奋剂治疗支气管哮喘急性发作患者的效果[J]. 河南医学研究, 2020, 29(14): 2596-2598. |
| [19] | 蒋娜. 细菌溶解产物辅助抗菌药物对支气管哮喘患者伴急性呼吸道感染的临床疗效及对免疫功能的影响[J]. 抗感染药学, 2020, 17(11): 1687-1689. |
| [20] | 赵一波, 邢述, 付学奇. 细菌溶解产物联合常规对症治疗对COPD急性加重患者气道功能、炎症反应及免疫应答的影响[J]. 临床和实验医学杂志, 2020, 19(8): 852-855. |
| [21] | 黎鸣桃, 黄淑芹, 张可妃, 王仙芸. 细菌溶解产物胶囊联合布地奈德雾化吸入治疗对咳嗽变异性哮喘患儿免疫功能、气道功能的影响[J]. 临床和实验医学杂志, 2023, 22(2): 175-179. |
| [22] | 林木土, 王巧红, 许宝花. 细菌溶解产物胶囊联合常规药物治疗小儿支气管哮喘急性发作的临床效果[J]. 医学理论与实践, 2023, 36(5): 827-829 812. |
| [23] | 沈萍, 徐诗尧, 蒋熠. 细菌溶解产物胶囊联合布地奈德气雾剂治疗儿童支气管哮喘的效果及对肺功能的影响[J]. 大医生, 2023, 8(19): 50-53. |
| [24] | Zhang, C.-H. (2010) Treatment of 31 Cases of Allergic Rhinitis with Acupuncture plus Moving Cupping. Journal of Acupuncture and Tuina Science, 8, 93-95. https://doi.org/10.1007/s11726-010-0093-9 |
| [25] | 韩东园, 徐博怀, 余璐洁, 裘奇阳, 何勇. 变应性鼻炎非特异性免疫治疗的研究进展[J]. 新医学, 2022, 53(11): 806-809. |
| [26] | Janeczek, K.P., Emeryk, A. and Rapiejko, P. (2019) Effect of Polyvalent Bacterial Lysate on the Clinical Course of Pollen Allergic Rhinitis in Children. Advances in Dermatology and Allergology, 36, 504-505. https://doi.org/10.5114/ada.2019.87457 |
| [27] | 文卫平. 以调节性T细胞为作用靶点的细菌溶解产物对变应性鼻炎的免疫调控作[Z]. 广州: 中山大学, 2017-03-10. |
| [28] | 国家卫建委. 儿童肺炎支原体肺炎诊疗指南(2023年版) [J]. 中国合理用药探索, 2023, 20(3): 16-24. |
| [29] | 王红利, 冼凤仪, 许敏鸿. 小儿肺热咳喘颗粒联合甲泼尼龙琥珀酸钠治疗儿童重症支原体肺炎的效果研究[J]. 中国现代医学杂志, 2024, 34(6): 14-19. http://kns.cnki.net/kcms/detail/43.1225.R.20240227.1151.006.html |
| [30] | 刘静. 肺俞穴中药贴敷联合细菌溶解产物对小儿支原体肺炎疗效及免疫功能的影响[J]. 山西中医, 2022, 38(12): 42-44. |
| [31] | 戴小萍, 梅俊, 肖体海. 细菌溶解产物胶囊对反复肺炎支原体感染患儿肺功能及免疫功能的改善作用[J]. 吉林医学, 2023, 44(8): 2251-2254. |
| [32] | 孟名柱, 潘昌杰, 张浩, 陈晓霞. 基于胸部X线片的深度迁移学习模型早期诊断儿童肺炎支原体肺炎[J]. 放射学实践, 2024, 39(1): 37-41. |
